Doxorubicin which is part of the conventional chemotherapy combination for sarcoma is known to be cardiotoxic. GPX-150 could become one day the new Doxorubicin without the cardiotoxicity:
Doxorubicin which is part of the conventional chemotherapy combination for sarcoma is known to be cardiotoxic. GPX-150 could become one day the new Doxorubicin without the cardiotoxicity: